JP2025023916A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025023916A5 JP2025023916A5 JP2024178540A JP2024178540A JP2025023916A5 JP 2025023916 A5 JP2025023916 A5 JP 2025023916A5 JP 2024178540 A JP2024178540 A JP 2024178540A JP 2024178540 A JP2024178540 A JP 2024178540A JP 2025023916 A5 JP2025023916 A5 JP 2025023916A5
- Authority
- JP
- Japan
- Prior art keywords
- rna molecule
- pharmaceutical composition
- secretion
- immunostimulatory
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 230000003308 immunostimulating effect Effects 0.000 claims 8
- 230000028327 secretion Effects 0.000 claims 6
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 102000006992 Interferon-alpha Human genes 0.000 claims 3
- 108010047761 Interferon-alpha Proteins 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 2
- 229940044616 toll-like receptor 7 agonist Drugs 0.000 claims 2
- 102000008070 Interferon-gamma Human genes 0.000 claims 1
- 108010074328 Interferon-gamma Proteins 0.000 claims 1
- 102000003814 Interleukin-10 Human genes 0.000 claims 1
- 108090000174 Interleukin-10 Proteins 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 210000003719 b-lymphocyte Anatomy 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000036755 cellular response Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000002538 fungal effect Effects 0.000 claims 1
- 229960003130 interferon gamma Drugs 0.000 claims 1
- 229940076144 interleukin-10 Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000003071 parasitic effect Effects 0.000 claims 1
- 210000005134 plasmacytoid dendritic cell Anatomy 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 230000004936 stimulating effect Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2017057094 | 2017-03-24 | ||
| EPPCT/EP2017/057094 | 2017-03-24 | ||
| PCT/EP2018/057206 WO2018172426A1 (en) | 2017-03-24 | 2018-03-21 | Methods and compositions for stimulating immune response |
| JP2019551991A JP7651261B2 (ja) | 2017-03-24 | 2018-03-21 | 免疫応答を刺激するための方法及び組成物 |
| JP2022193597A JP2023036615A (ja) | 2017-03-24 | 2022-12-02 | 免疫応答を刺激するための方法及び組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193597A Division JP2023036615A (ja) | 2017-03-24 | 2022-12-02 | 免疫応答を刺激するための方法及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025023916A JP2025023916A (ja) | 2025-02-19 |
| JP2025023916A5 true JP2025023916A5 (enExample) | 2025-03-03 |
Family
ID=61911533
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019551991A Active JP7651261B2 (ja) | 2017-03-24 | 2018-03-21 | 免疫応答を刺激するための方法及び組成物 |
| JP2022193597A Pending JP2023036615A (ja) | 2017-03-24 | 2022-12-02 | 免疫応答を刺激するための方法及び組成物 |
| JP2024178540A Pending JP2025023916A (ja) | 2017-03-24 | 2024-10-11 | 免疫応答を刺激するための方法及び組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019551991A Active JP7651261B2 (ja) | 2017-03-24 | 2018-03-21 | 免疫応答を刺激するための方法及び組成物 |
| JP2022193597A Pending JP2023036615A (ja) | 2017-03-24 | 2022-12-02 | 免疫応答を刺激するための方法及び組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11471522B2 (enExample) |
| EP (2) | EP3600389B1 (enExample) |
| JP (3) | JP7651261B2 (enExample) |
| AU (1) | AU2018240421B2 (enExample) |
| CA (1) | CA3056819A1 (enExample) |
| ES (1) | ES2951684T3 (enExample) |
| WO (1) | WO2018172426A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3056819A1 (en) | 2017-03-24 | 2018-09-27 | Biontech Rna Pharmaceuticals Gmbh | Methods and compositions for stimulating immune response |
| AU2021252164A1 (en) | 2020-04-09 | 2022-12-15 | Finncure Oy | Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses |
| US12194157B2 (en) | 2020-04-09 | 2025-01-14 | Finncure Oy | Carrier for targeted delivery to a host |
| WO2022099003A1 (en) * | 2020-11-06 | 2022-05-12 | Sanofi | Lipid nanoparticles for delivering mrna vaccines |
| CN114733455B (zh) * | 2022-04-15 | 2023-02-14 | 北京田园奥瑞生物科技有限公司 | 一种利用生物改性β-环糊精纳米磁颗粒进行快速哺乳动物精子分型的方法 |
| WO2025144938A1 (en) | 2023-12-26 | 2025-07-03 | Emmune, Inc. | Systems for nucleic acid transfer |
| WO2025223684A1 (en) | 2024-04-23 | 2025-10-30 | BioNTech SE | Methods and compositions for stimulating immune response |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200533750A (en) | 2004-02-19 | 2005-10-16 | Coley Pharm Group Inc | Immunostimulatory viral RNA oligonucleotides |
| EP2167662A2 (en) * | 2007-05-14 | 2010-03-31 | Technische Universität München | Pharmaceutical compounds comprising abasic oligonucleotides |
| US10174326B2 (en) * | 2009-03-17 | 2019-01-08 | Rheinische Friedrich-Wilhelms-Universität Bonn | TLR7 ligand and uses thereof |
| CA2786940C (en) * | 2010-03-16 | 2019-09-24 | Biontech Ag | Tumor vaccination involving a humoral immune response, and proteins therefor including all or a portion of a hepatitis b virus core antigen protein and an epitope of claudin 18.2 |
| EP2819703A4 (en) * | 2012-02-29 | 2015-11-18 | Benitec Biopharma Ltd | PAIN TREATMENT |
| US10624964B2 (en) * | 2015-05-01 | 2020-04-21 | The Trustees Of The University Of Pennsylvania | Methods and compositions for stimulating immune response using potent immunostimulatory RNA motifs |
| CA3003103A1 (en) | 2015-10-22 | 2017-04-27 | Modernatx, Inc. | Broad spectrum influenza virus vaccine |
| CA3056819A1 (en) | 2017-03-24 | 2018-09-27 | Biontech Rna Pharmaceuticals Gmbh | Methods and compositions for stimulating immune response |
-
2018
- 2018-03-21 CA CA3056819A patent/CA3056819A1/en active Pending
- 2018-03-21 EP EP18716138.5A patent/EP3600389B1/en active Active
- 2018-03-21 WO PCT/EP2018/057206 patent/WO2018172426A1/en not_active Ceased
- 2018-03-21 AU AU2018240421A patent/AU2018240421B2/en active Active
- 2018-03-21 JP JP2019551991A patent/JP7651261B2/ja active Active
- 2018-03-21 ES ES18716138T patent/ES2951684T3/es active Active
- 2018-03-21 EP EP23172071.5A patent/EP4241786A3/en active Pending
- 2018-03-21 US US16/496,858 patent/US11471522B2/en active Active
-
2022
- 2022-09-12 US US17/931,215 patent/US12168051B2/en active Active
- 2022-12-02 JP JP2022193597A patent/JP2023036615A/ja active Pending
-
2024
- 2024-10-11 JP JP2024178540A patent/JP2025023916A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025023916A5 (enExample) | ||
| Wang et al. | STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice | |
| Wu et al. | Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue | |
| JP2023176003A5 (enExample) | ||
| Sakai et al. | Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells. | |
| Portier et al. | In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma | |
| JPWO2021214204A5 (enExample) | ||
| WO2018228538A1 (zh) | 重组单纯疱疹病毒及其制备方法和应用 | |
| WO2019080537A1 (zh) | 包含溶瘤病毒和car-nk细胞的治疗剂及应用、药盒、治疗肿瘤和/或癌症的方法 | |
| US9714272B2 (en) | Recombinant proteins of parapdxvirus ovis and pharmaceutical compositions therefrom | |
| WO2019062233A1 (zh) | 包含分离的重组溶瘤痘病毒和nk细胞的治疗剂及应用、药盒、治疗肿瘤和/或癌症的方法 | |
| JPH06504785A (ja) | インターロイキン−１０による腫瘍性疾患の処置 | |
| CN102027104A (zh) | 含有细胞因子诱导杀伤细胞的细胞群的制造方法 | |
| US11098283B2 (en) | T cells modified to overexpress c-Myb | |
| Namkoong et al. | Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11 | |
| JP2021521828A (ja) | ヒドロキシクエン酸および／またはその塩を使用してｔ細胞集団を産生する方法 | |
| CN101063142B (zh) | 人乳头瘤病毒16型dna疫苗和基因佐剂及其应用 | |
| CN108486120B (zh) | 一种新型CpG ODN序列及其在抗黑色素瘤上的应用 | |
| CN109415410B (zh) | 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗 | |
| CN103547286B (zh) | 一种用于预防和治疗乙型肝炎的dna疫苗组合物 | |
| CN118221773B (zh) | 与HLA相关的CMV pp65表位疫苗组合物与应用 | |
| EP2647645A1 (en) | Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom | |
| JPWO2020074902A5 (enExample) | ||
| WO2024138753A1 (zh) | 一种hla-a*24:02限制性抗原点替换方法、获得的多肽及其应用 | |
| Lattime et al. | In Situ Gene Insertion for Immunotherapy Using Vaccinia Virus Vectors |